Reports
Sale
Global Diagnostic Testing Market Size, Trends, Forecast: By Test: Lipid Panel, Liver Panel, Renal Panel, Complete Blood Count, Electrolyte Testing, Infectious Disease Testing, Other Tests; By Type: Product, Instruments, Reagents, Other Products; By End User: Hospital Laboratory, Other End Users; Regional Analysis; Supplier Landscape; 2024-2032
Global Diagnostic Testing Market Outlook
The global diagnostic testing market size was valued at USD 191.55 billion in 2023, driven by the increasing innovation in diagnostic testing techniques across the globe. The market size is anticipated to grow at a CAGR of 8.1% during the forecast period of 2024-2032 to achieve a value of USD 386.12 billion by 2032.
Diagnostic Testing: Introduction
Diagnosis testing, a fundamental pillar of modern healthcare, involves a diverse range of tests and examinations aimed at identifying the presence of specific diseases, conditions, or health issues in individuals. Through laboratory tests, imaging techniques, genetic analysis, biopsies, and other diagnostic procedures, healthcare professionals can make accurate and timely diagnoses. Early detection facilitated by these tests enables prompt intervention and treatment, leading to improved patient outcomes.
Diagnostic testing not only confirms or rules out suspected diagnoses but also plays a crucial role in disease monitoring and the implementation of personalized medicine approaches. Additionally, it is instrumental in public health surveillance, allowing for the monitoring of infectious diseases and timely containment of outbreaks.
Global Diagnostic Testing Market Analysis
Diagnostic testing provides convenience, faster results, and ease of use for patients and healthcare providers, leading to increased demand for point-of-care testing (POCT). With the help of POCT devices, rapid diagnosis and treatment decisions could be made quickly in clinics, or even in remote settings, which leads to the reduction in time of fetching test results. These benefits increase the demand for better diagnostic testing procedures that are convenient for both healthcare professionals and the patients, driving the market growth.
Additionally, due to its great sensitivity and specificity in detecting and analyzing genetic material, infections, and biomarkers, molecular diagnostics is also experiencing substantial growth, which is directly adding up to the global diagnostic testing market share. The integration of diagnostic testing with digital health technologies, such as telemedicine, mobile health apps, and wearable devices, has also gained enough popularity among patients and healthcare professionals. With the help of these technologies, remote monitoring, data collection, and real-time communication between patients and healthcare providers is made easy which further enhances the overall patient experience and improves the disease management approaches.
To keep up with the needs of modern healthcare, the market is constantly evolving. The market is changing, and diagnostic skills are being upgraded for better patient care as a result of technological innovations, personalized healthcare, digital health integration, and ongoing responses to global health concerns.
Global Diagnostic Testing Market Segmentations
Market Breakup by Test
- Lipid Panel
- Liver Panel
- Renal Panel
- Complete Blood Count
- Electrolyte Testing
- Infectious Disease Testing
- Other Tests
Market Breakup by Type
- Product
- Instruments
- Reagents
- Other Products
Market Breakup by End User
- Hospital Laboratory
- Diagnostic Laboratory
- Point-of-care Testing
- Other End Users
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Global Diagnostic Testing Market Overview
The market is a rapidly evolving and is an important part of the healthcare industry across the globe. It includes a wide range of procedures and equipment for examining illnesses, disorders, infections, and genetic disorders in people. The rising geriatric population, improvements in diagnostic technology, the rising demand for early disease diagnosis, and increasing focus on personalized medicines and healthcare, integration of smart technologies such as artificial intelligence and machine learning with diagnostic devices are some of the major factors that have been propelling the global diagnostic testing market growth. There are some major kinds of diagnostic testing included in the market which are molecular diagnostics, immunoassays, point-of-care testing, clinical chemistry, and medical imaging.
Diagnostic testing continues to play an important role in enhancing patient outcomes, enhancing treatment plans, and promoting effective disease management as the focus on preventative healthcare and quick treatments is increasing.
Moreover, the ongoing efforts to fight global health crises have further showed the significance of diagnostic testing in identifying and containing infectious diseases. With ongoing research and technological innovations, the market is expected to witness substantial growth in the coming years, contributing significantly to advancing healthcare and promoting better public health outcomes.
Diagnostic Testing Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Abbott Laboratories
- Becton, Dickinson and Company
- BioMerieux
- Bio-Rad Laboratories Inc.
- Danaher Corporation
- Siemens AG
- Hologic Inc.
- Qiagen NV
- F. Hoffmann-La Roche AG
- Thermo Fisher Scientific
- Quest Diagnostics Inc.
- Sysmex Corporation
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Test |
|
| Breakup by Type |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Diagnostic Testing Market Overview
3.1 Global Diagnostic Testing Market Historical Value (2017-2023)
3.2 Global Diagnostic Testing Market Forecast Value (2024-2032)
4 Global Diagnostic Testing Market Landscape
4.1 Global Diagnostic Testing: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Diagnostic Testing: Product Landscape
4.2.1 Analysis by Test Type
4.2.2 Analysis by Technology
4.2.3 Analysis by Applications
5 Global Diagnostic Testing Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Diagnostic Testing Market Segmentation
6.1 Global Diagnostic Testing Market by Test
6.1.1 Market Overview
6.1.2 Lipid Panel
6.1.3 Liver Panel
6.1.4 Renal Panel
6.1.5 Complete Blood Count
6.1.6 Electrolyte Testing
6.1.7 Infectious Disease Testing
6.1.8 Other Tests
6.2 Global Diagnostic Testing Market by Type
6.2.1 Market Overview
6.2.2 Product
6.2.3 Instruments
6.2.4 Reagents
6.2.5 Other Products
6.3 Global Diagnostic Testing Market by End User
6.3.1 Market Overview
6.3.2 Hospital Laboratory
6.3.3 Diagnostic Laboratory
6.3.4 Point-of-care Testing
6.3.5 Other End Users
6.4 Global Diagnostic Testing Market by Region
6.4.1 Market Overview
6.4.2 North America
6.4.3 Europe
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Diagnostic Testing Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Diagnostic Testing Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Diagnostic Testing Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Diagnostic Testing Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Diagnostic Testing Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Regulatory Framework
12.1 Regulatory Overview
12.1.1 US FDA
12.1.2 EU EMA
12.1.3 INDIA CDSCO
12.1.4 JAPAN PMDA
12.1.5 Others
13 Patent Analysis
13.1 Analysis by Type of Patent
13.2 Analysis by Publication year
13.3 Analysis by Issuing Authority
13.4 Analysis by Patent Age
13.5 Analysis by CPC Analysis
13.6 Analysis by Patent Valuation
13.7 Analysis by Key Players
14 Grants Analysis
14.1 Analysis by year
14.2 Analysis by Amount Awarded
14.3 Analysis by Issuing Authority
14.4 Analysis by Grant Application
14.5 Analysis by Funding Institute
14.6 Analysis by NIH Departments
14.7 Analysis by Recipient Organization
15 Clinical Trials Analysis
15.1 Analysis by Trial Registration Year
15.2 Analysis by Trial Status
15.3 Analysis by Trial Phase
15.4 Analysis by Therapeutic Area
15.5 Analysis by Geography
16 Funding and Investment Analysis
16.1 Analysis by Funding Instances
16.2 Analysis by Type of Funding
16.3 Analysis by Funding Amount
16.4 Analysis by Leading Players
16.5 Analysis by Leading Investors
16.6 Analysis by Geography
17 Partnership and Collaborations Analysis
17.1 Analysis by Partnership Instances
17.2 Analysis by Type of Partnership
17.3 Analysis by Leading Players
17.4 Analysis by Geography
18 Supplier Landscape
18.1 Abbott Laboratories
18.1.1 Financial Analysis
18.1.2 Product Portfolio
18.1.3 Demographic Reach and Achievements
18.1.4 Mergers and Acquisitions
18.1.5 Certifications
18.2 Becton, Dickinson and Company
18.2.1 Financial Analysis
18.2.2 Product Portfolio
18.2.3 Demographic Reach and Achievements
18.2.4 Mergers and Acquisitions
18.2.5 Certifications
18.3 BioMerieux
18.3.1 Financial Analysis
18.3.2 Product Portfolio
18.3.3 Demographic Reach and Achievements
18.3.4 Mergers and Acquisitions
18.3.5 Certifications
18.4 Bio-Rad Laboratories Inc.
18.4.1 Financial Analysis
18.4.2 Product Portfolio
18.4.3 Demographic Reach and Achievements
18.4.4 Mergers and Acquisitions
18.4.5 Certifications
18.5 Danaher Corporation
18.5.1 Financial Analysis
18.5.2 Product Portfolio
18.5.3 Demographic Reach and Achievements
18.5.4 Mergers and Acquisitions
18.5.5 Certifications
18.6 Siemens AG
18.6.1 Financial Analysis
18.6.2 Product Portfolio
18.6.3 Demographic Reach and Achievements
18.6.4 Mergers and Acquisitions
18.6.5 Certifications
18.7 Hologic Inc.
18.7.1 Financial Analysis
18.7.2 Product Portfolio
18.7.3 Demographic Reach and Achievements
18.7.4 Mergers and Acquisitions
18.7.5 Certifications
18.8 Qiagen NV
18.8.1 Financial Analysis
18.8.2 Product Portfolio
18.8.3 Demographic Reach and Achievements
18.8.4 Mergers and Acquisitions
18.8.5 Certifications
18.9 F. Hoffmann-La Roche AG
18.9.1 Financial Analysis
18.9.2 Product Portfolio
18.9.3 Demographic Reach and Achievements
18.9.4 Mergers and Acquisitions
18.9.5 Certifications
18.10 Thermo Fisher Scientific
18.10.1 Financial Analysis
18.10.2 Product Portfolio
18.10.3 Demographic Reach and Achievements
18.10.4 Mergers and Acquisitions
18.10.5 Certifications
18.11 Quest Diagnostics Inc.
18.11.1 Financial Analysis
18.11.2 Product Portfolio
18.11.3 Demographic Reach and Achievements
18.11.4 Mergers and Acquisitions
18.11.5 Certifications
18.12 Sysmex Corporation
18.12.1 Financial Analysis
18.12.2 Product Portfolio
18.12.3 Demographic Reach and Achievements
18.12.4 Mergers and Acquisitions
18.12.5 Certifications
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
Key Questions Answered in the Report
The market attained a value of about USD 191.55 billion in 2023, driven by the increasing demand for minimally invasive diagnosis procedures.
The market is anticipated to grow at a CAGR of 8.1% during the forecast period of 2024-2032, likely to reach a value of USD 386.12 billion by 2032.
The ongoing research and technological innovations, along with the rapidly rising geriatric population are among the major factors driving the market growth.
The increasing adoption of molecular diagnostic due to its great sensitivity and specificity in detecting and analyzing genetic material is a major trend influencing the market growth.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East and Africa. North America is currently leading the global market.
The kinds of tests available in the market include lipid panel, liver panel, renal panel, complete blood count, electrolyte testing, and infectious disease testing, among other tests.
Types of diagnostic testing include product, instruments, reagents, among others.
End users in the market include hospital laboratory, diagnostic laboratory, point-of-care testing, among other end users.
Key players involved in the market are Abbott Laboratories, Becton, Dickinson and Company, BioMerieux, Bio-Rad Laboratories Inc., Danaher Corporation, Siemens AG, Hologic Inc., Qiagen NV, F. Hoffmann-La Roche AG, Thermo Fisher Scientific, Quest Diagnostics Inc., and Sysmex Corporation.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2969
$2699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5499
$4999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 6599
$5999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 7699
$6999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER